Faryabi R, Kamali A, Raesi R, Hushmandi K, Tabatabaee SS, Askarpour H, Samakkhah SA, Daneshi S. Effects of COVID-19 pandemic on pulmonary tuberculosis (TB) occurrence in the South of Iran. Curr Respiratory Med Reviews. 2025;21(3):267–75.
Google Scholar
Organization WH. Global tuberculosis report 2021: supplementary material. World Health Organization; 2022.
Lee SH. Tuberculosis infection and latent tuberculosis. Tuberc Respir Dis. 2016;79(4):201.
Faryabi R, Raesi R, Taghdisi Heydarian SM, Daneshi S, Kermani B, Hushmandi K, Barfar E. Evaluation of the tuberculosis surveillance system in the Southern Region of Iran. Open Public Health J. 2024;17(1):e18749445275993.
Talip BA, Sleator RD, Lowery CJ, Dooley JS, Snelling WJ. An update on global tuberculosis (TB). Infect Diseases: Res Treat. 2013;6:IDRT. S11263.
Puyat JH, Brode SK, Shulha H, Romanowski K, Menzies D, Benedetti A, Duchen R, Huang A, Fang J, Macdonald L. Predicting risk of tuberculosis (TB) disease in people who migrate to a Low-TB incidence country: development and validation of a multivariable, dynamic risk-Prediction model using health administrative data. Clin Infect Dis. 2025;80(3):644–52.
Google Scholar
Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med. 2016;13(10):e1002152.
Google Scholar
Gustafsson N, Leino-Kilpi H, Prga I, Suhonen R, Stolt M. Action–CA15208 RcC: Missed care from the patient’s perspective–a scoping review. Patient Prefer Adherence. 2020;14:383–400.
Google Scholar
Chakaya J, Petersen E, Nantanda R, Mungai BN, Migliori GB, Amanullah F, Lungu P, Ntoumi F, Kumarasamy N, Maeurer M. The WHO global tuberculosis 2021 Report–not so good news and turning the tide back to end TB. Int J Infect Dis. 2022;124:S26–9.
Google Scholar
Bagcchi S. WHO’s global tuberculosis report 2022. Lancet Microbe. 2023;4(1):e20.
Google Scholar
Rastegar M, Nazar E, Nasehi M, Sharafi S, Fakoor V, Shakeri MT. Bayesian Estimation of the time-varying reproduction number for pulmonary tuberculosis in iran: a registry-based study from 2018 to 2022 using new smear-positive cases. Infect Disease Modelling. 2024;9(3):963–74.
Song H-W, Tian J-H, Song H-P, Guo S-J, Lin Y-H, Pan J-S. Tracking multidrug resistant tuberculosis: a 30-year analysis of global, regional, and National trends. Front Public Health. 2024;12:1408316.
Google Scholar
Srivastava V, Verma A. Current challenges in the management of tuberculosis. J Young Pharmacists. 2024;16(2):145–54.
Google Scholar
Hassan AO. Social support and treatment outcomes among multi-drug-resistant tuberculosis and persons living with HIV in Nigeria. Walden University; 2025.
Ehsani R, Sharafoddin M, Olyaeemanesh A, Delavari A, Vosoogh-Moghaddam A, Alimohamadi Y, Ghorbani S. Insights into health program implementation and evaluation in iran: A brief review of National healthcare programs in Iran. Iran J Public Health. 2024;53(11):2572.
Google Scholar
Nasiri MJ, Dabiri H, Darban-Sarokhalil D, Rezadehbashi M, Zamani S. Prevalence of drug-resistant tuberculosis in iran: systematic review and meta-analysis. Am J Infect Control. 2014;42(11):1212–8.
Google Scholar
Ayoubi S, Farnia P, Farnia P, Ghanavi J, Velayati AA. Prevalence and Temporal trends of multidrug-resistant tuberculosis in Iran from 1981 to 2023: a systematic review and meta-analysis. Int J Mycobacteriology. 2024;13(3):320–30.
Chowdhury K, Ahmad R, Sinha S, Dutta S, Haque M. Multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) among children: where we stand now. Cureus. 2023;15(2):e35154.
Google Scholar
Koch A, Cox H, Mizrahi V. Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment. Curr Opin Pharmacol. 2018;42:7–15.
Google Scholar
Dookie N, Ngema SL, Perumal R, Naicker N, Padayatchi N, Naidoo K. The changing paradigm of drug-resistant tuberculosis treatment: successes, pitfalls, and future perspectives. Clin Microbiol Rev. 2022;35(4):e00180–00119.
Google Scholar
Chen Z, Wang T, Du J, Sun L, Wang G, Ni R, An Y, Fan X, Li Y, Guo R. Decoding the WHO global tuberculosis report 2024: A critical analysis of global and Chinese key data. Zoonoses. 2025;5(1):999.
Google Scholar
Stephanie F, Saragih M, Tambunan USF. Recent progress and challenges for drug-resistant tuberculosis treatment. Pharmaceutics. 2021;13(5):592.
Google Scholar
Bialvaei AZ, Asgharzadeh M, Aghazadeh M, Nourazarian M, Kafil HS. Challenges of tuberculosis in Iran. Jundishapur J Microbiol. 2017;10(3):e37866.
Madadi-Goli N, Ahmadi K, Meskini M, Vaziri F, Fateh A, Siadat SD. Tuberculosis prevention, diagnosis, and treatment financial profile during 2006–2021: part B. J Prev Diagn Treat Strategies Med. 2024;3(1):37–43.
Moosazadeh M, Amiresmaili M. Challenges in case finding of tuberculosis control program in iran: A qualitative study. Bangladesh J Med Sci. 2018;17(3):462–9.
Kazerooni P, Nejat M, Akbarpoor M, Sedaghat Z, Fararouei M. Underascertainment, underreporting, representativeness and timeliness of the Iranian communicable disease surveillance system for tuberculosis. Public Health. 2019;171:50–6.
Google Scholar
Khademi F, Yousefi-Avarvand A, Derakhshan M, Vaez H, Sadeghi R. Middle East Mycobacterium tuberculosis antibiotic resistance: a systematic review and meta-analysis. Infect Epidemiol Microbiol. 2017;3(1):25–35.
Abbasian S, Heidari H, Tadi DA, Kardan-Yamchi J, Taji A, Darbandi A, Asadollahi P, Maleki A, Kazemian H. Epidemiology of first-and second-line drugs-resistant pulmonary tuberculosis in iran: systematic review and meta-analysis. J Clin Tuberculosis Other Mycobact Dis. 2024;35:100430.
Google Scholar
Bahraminia F, Azimi T, Zangiabadian M, Nasiri MJ, Goudarzi M, Dadashi M, Fooladi AAI. Rifampicin-resistant tuberculosis in iran: A systematic review and meta-analysis. Iran J Basic Med Sci. 2021;24(6):720.
Google Scholar
Alibrahim A, Alqahtani H, Thirunavukkarasu A, Qazi I. Prevalence, patterns, and determinants of drug-resistant tuberculosis in Gulf Cooperation Council countries: an updated systematic review. PeerJ. 2024;12:e18628.
Google Scholar
Munir MA, Khan S, Rehman S, Ahmed D, Jabbar A. Tuberculosis among diabetes patients: a review of epidemiology, pathophysiology, clinical manifestations, and management. Chronicles Biomedical Sci. 2024;1(3):PID26–26.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
Google Scholar
Schardt C, Adams MB, Owens T, Keitz S, Fontelo P. Utilization of the PICO framework to improve searching pubmed for clinical questions. BMC Med Inf Decis Mak. 2007;7:1–6.
Sguanci M, Mancin S, Piredda M, De Marinis MG. Protocol for conducting a systematic review on diagnostic accuracy in clinical research. MethodsX. 2024;12:102569.
Google Scholar
Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, Stephenson M, Aromataris E. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synthesis. 2020;18(10):2127–33.
Sguanci M, Ferrara G, Palomares SM, Parozzi M, Godino L, Gazineo D, Anastasi G, Mancin S. Dysgeusia and chronic kidney disease: a scoping review. J Ren Nutr. 2024;34:374.
Google Scholar
Howick J. The Oxford 2011 levels of evidence. http://www.cebm.net /index aspx? o = 5653 2011.
Mancin S, Sguanci M, Andreoli D, Soekeland F, Anastasi G, Piredda M, De Marinis MG. Systematic review of clinical practice guidelines and systematic reviews: a method for conducting comprehensive analysis. MethodsX. 2024;12:102532.
Google Scholar
Mohajeri P, Sadri H, Farahani A, Norozi B, Atashi S. Frequency of mutations associated with rifampicin resistance in Mycobacterium tuberculosis strains isolated from patients in West of Iran. Microb Drug Resist. 2015;21(3):315–9.
Google Scholar
Tabarsi P, Chitsaz E, Baghaei P, Shamaei M, Farnia P, Marjani M, Kazempour M, Amiri M, Mansouri D, Masjedi MR. Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran. Microb Drug Resist. 2010;16(1):81–6.
Google Scholar
Velayati AA, Masjedi MR, Farnia P, Tabarsi P, Ghanavi J, ZiaZarifi AH, Hoffner SE. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran. Chest. 2009;136(2):420–5.
Google Scholar
Mohajeri P, Moradi S, Atashi S, Farahani A. Mycobacterium tuberculosis Beijing genotype in Western iran: distribution and drug resistance. J Clin Diagn Research: JCDR. 2016;10(10):DC05.
Google Scholar
Doustdar F, Khosravi AD, Farnia P, Masjedi MR, Velayati AA. Molecular analysis of Isoniazid resistance in different genotypes of Mycobacterium tuberculosis isolates from Iran. Microb Drug Resist. 2008;14(4):273–9.
Google Scholar
Lee H, Kim J, Kim J, Park Y-J. Review of the global burden of tuberculosis in 2023: insights from the WHO Global Tuberculosis Report 2024. 2025.
Tuberculosis. incidence in Iran. https://www.theglobaleconomy.com/Iran/Tuberculosis/?utm_source=chatgpt.com
Ebrahimzadeh A, Pagheh AS, Mousavi T, Fathi M, Moghaddam SGM. Serosal membrane tuberculosis in iran: A comprehensive review of evidences. J Clin Tuberculosis Other Mycobact Dis. 2023;31:100354.
Google Scholar
Yuanyuan L, Jingjing X, Shutao L, Dongdong S, Tian Z, Puxuan L, Yi P. 2024 WHO tuberculosis report: key data analysis for China and the global world. Electron J Emerg Infect Dis. 2025;9(6):92.
Zumla A, George A, Sharma V, Herbert N. WHO’s 2013 global report on tuberculosis: successes, threats, and opportunities. Lancet. 2013;382(9907):1765–7.
Google Scholar
Gizaw Z, Astale T, Kassie GM. What improves access to primary healthcare services in rural communities? A systematic review. BMC Prim Care. 2022;23(1):313.
Google Scholar
Douthit N, Kiv S, Dwolatzky T, Biswas S. Exposing some important barriers to health care access in the rural USA. Public Health. 2015;129(6):611–20.
Google Scholar
Yu SW, Hill C, Ricks ML, Bennet J, Oriol NE. The scope and impact of mobile health clinics in the united states: a literature review. Int J Equity Health. 2017;16:1–12.
Javanparast S, Windle A, Freeman T, Baum F. Community health worker programs to improve healthcare access and equity: are they only relevant to low-and middle-income countries? Int J Health Policy Manage. 2018;7(10):943.
Nunemo MH, Gidebo KD, Woticha EW, Lemu YK. Integration challenges and opportunity of implementing non-communicable disease screening intervention with tuberculosis patient care: A mixed implementation study. Risk Manage Healthc Policy. 2023;16:2609–33.
Arini M, Sugiyo D, Permana I. Challenges, opportunities, and potential roles of the private primary care providers in tuberculosis and diabetes mellitus collaborative care and control: a qualitative study. BMC Health Serv Res. 2022;22(1):215.
Google Scholar
Wagnew F, Gray D, Tsheten T, Kelly M, Clements AC, Alene KA. Effectiveness of nutritional support to improve treatment adherence in patients with tuberculosis: a systematic review. Nutr Rev. 2024;82(9):1216–25.
Google Scholar
Saidi SS, Abdul Manaf R. Effectiveness of family support health education intervention to improve health-related quality of life among pulmonary tuberculosis patients in melaka, Malaysia. BMC Pulm Med. 2023;23(1):139.
Google Scholar
Palomino JC, Martin A. Drug resistance mechanisms in Mycobacterium tuberculosis. Antibiotics. 2014;3(3):317–40.
Google Scholar
Ramirez MV, Cowart KC, Campbell PJ, Morlock GP, Sikes D, Winchell JM, Posey JE. Rapid detection of Multidrug-Resistant Mycobacterium tube rculosis by use of Real-Time PCR and High-Resolution melt analysis. J Clin Microbiol. 2010;48(11):4003–9.
Google Scholar
Ong DC, Yam W-C, Siu GK, Lee AS. Rapid detection of rifampicin-and isoniazid-resistant Mycobacterium tuberculosis by high-resolution melting analysis. J Clin Microbiol. 2010;48(4):1047–54.
Google Scholar
Yin X, Zheng L, Liu Q, Lin L, Hu X, Hu Y, Wang Q. High-resolution melting curve analysis for rapid detection of Rifampin resistance in Mycobacterium tuberculosis: a meta-analysis. J Clin Microbiol. 2013;51(10):3294–9.
Google Scholar
Walker TM, Kohl TA, Omar SV, Hedge J, Elias CDO, Bradley P, Iqbal Z, Feuerriegel S, Niehaus KE, Wilson DJ. Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect Dis. 2015;15(10):1193–202.
Google Scholar
Sheikh BA, Bhat BA, Mehraj U, Mir W, Hamadani S, Mir MA. Development of new therapeutics to Meet the current challenge of drug resistant tuberculosis. Curr Pharm Biotechnol. 2021;22(4):480–500.
Google Scholar
Terreni M, Taccani M, Pregnolato M. New antibiotics for multidrug-resistant bacterial strains: latest research developments and future perspectives. Molecules. 2021;26(9):2671.
Google Scholar